Morning Overview on MSN
New CRISPR technique flips genes on without cutting DNA
Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...
CRISPR Therapeutics' stock is down 19% since December, with a slow Casgevy launch and significant R&D investments, yet strong cash reserves provide a safety net. Q4 earnings show no revenue from ...
Simply Recipes on MSN
You’re using the crisper drawer wrong—stop doing this with your vegetables
If the crisper drawers in your refrigerator don’t have different settings, consider them to be high-humidity drawers. You can ...
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its ...
Financial giants have made a conspicuous bearish move on CRISPR Therapeutics. Our analysis of options history for CRISPR Therapeutics (NASDAQ:CRSP) revealed 9 unusual trades. Delving into the details, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback